Trademark: 87982295
Word
ONCO/REVEAL
Status
Registered
Status Code
700
Status Date
Tuesday, July 28, 2020
Serial Number
87982295
Registration Number
6114090
Registration Date
Tuesday, July 28, 2020
Mark Type
4000
Filing Date
Friday, September 22, 2017
Published for Opposition
Tuesday, March 20, 2018

Trademark Owner History
Pillar Biosciences, Inc. - Original Registrant

Classifications
1 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research
5 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer
9 Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing
ON CO/REVEAL

Trademark Events
Jul 28, 2020
Registered-Principal Register
Jun 26, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 25, 2020
Allowed Principal Register - Sou Accepted
Jun 2, 2020
Teas/Email Correspondence Entered
Jun 2, 2020
Correspondence Received In Law Office
May 29, 2020
Assigned To Lie
May 21, 2020
Teas Response To Office Action Received
Nov 26, 2019
Notification Of Non-Final Action E-Mailed
Nov 26, 2019
Non-Final Action E-Mailed
Nov 26, 2019
Su - Non-Final Action - Written
Nov 14, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2019
Statement Of Use Processing Complete
Nov 11, 2019
Use Amendment Filed
Nov 13, 2019
Divisional Processing Complete
Nov 11, 2019
Divisional Request Received
Nov 13, 2019
Extension 3 Granted
Nov 11, 2019
Extension 3 Filed
Nov 11, 2019
Teas Request To Divide Received
Nov 11, 2019
Teas Extension Received
Nov 11, 2019
Teas Statement Of Use Received
May 30, 2019
Notice Of Approval Of Extension Request E-Mailed
May 30, 2019
Corrected Noa E-Mailed
May 29, 2019
Divisional Processing Complete
May 10, 2019
Divisional Request Received
May 29, 2019
Extension 2 Granted
May 10, 2019
Extension 2 Filed
May 29, 2019
Case Assigned To Intent To Use Paralegal
May 10, 2019
Teas Request To Divide Received
May 10, 2019
Teas Extension Received
Nov 17, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 15, 2018
Extension 1 Granted
Nov 15, 2018
Extension 1 Filed
Nov 15, 2018
Teas Extension Received
May 15, 2018
Noa E-Mailed - Sou Required From Applicant
Mar 20, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 20, 2018
Published For Opposition
Feb 28, 2018
Notification Of Notice Of Publication E-Mailed
Feb 8, 2018
Approved For Pub - Principal Register
Jan 25, 2018
Teas/Email Correspondence Entered
Jan 24, 2018
Correspondence Received In Law Office
Jan 24, 2018
Teas Response To Office Action Received
Jan 4, 2018
Notification Of Non-Final Action E-Mailed
Jan 4, 2018
Non-Final Action E-Mailed
Jan 4, 2018
Non-Final Action Written
Dec 28, 2017
Assigned To Examiner
Sep 28, 2017
New Application Office Supplied Data Entered In Tram
Sep 26, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24